These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36202184)
1. Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors. Chen G; Zhu X; Li J; Zhang Y; Wang X; Zhang R; Qin X; Chen X; Wang J; Liao W; Wu Z; Lu L; Wu W; Yu H; Ma L Pharmacol Res; 2022 Nov; 185():106487. PubMed ID: 36202184 [TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy. Shetty MG; Pai P; Deaver RE; Satyamoorthy K; Babitha KS Pharmacol Res; 2021 Aug; 170():105695. PubMed ID: 34082029 [TBL] [Abstract][Full Text] [Related]
3. Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide. Hajji N; Wallenborg K; Vlachos P; Füllgrabe J; Hermanson O; Joseph B Oncogene; 2010 Apr; 29(15):2192-204. PubMed ID: 20118981 [TBL] [Abstract][Full Text] [Related]
4. Novel histone deacetylase inhibitors derived from Magnolia officinalis significantly enhance TRAIL-induced apoptosis in non-small cell lung cancer. Liu Y; Tong Y; Yang X; Li F; Zheng L; Liu W; Wu J; Ou R; Zhang G; Hu M; Liu Z; Lu L Pharmacol Res; 2016 Sep; 111():113-125. PubMed ID: 27268146 [TBL] [Abstract][Full Text] [Related]
5. A 6-alkylsalicylate histone acetyltransferase inhibitor inhibits histone acetylation and pro-inflammatory gene expression in murine precision-cut lung slices. van den Bosch T; Leus NGJ; Wapenaar H; Boichenko A; Hermans J; Bischoff R; Haisma HJ; Dekker FJ Pulm Pharmacol Ther; 2017 Jun; 44():88-95. PubMed ID: 28323055 [TBL] [Abstract][Full Text] [Related]
6. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation. Hutt DM; Roth DM; Marchal C; Bouchecareilh M Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814 [TBL] [Abstract][Full Text] [Related]
7. Role of histone deacetylases and their inhibitors in neurological diseases. Zhang LY; Zhang SY; Wen R; Zhang TN; Yang N Pharmacol Res; 2024 Oct; 208():107410. PubMed ID: 39276955 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous NF-κB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo. Zheng L; Fu Y; Zhuang L; Gai R; Ma J; Lou J; Zhu H; He Q; Yang B Int J Cancer; 2014 Oct; 135(7):1721-32. PubMed ID: 24615207 [TBL] [Abstract][Full Text] [Related]
9. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity. Leus NG; van der Wouden PE; van den Bosch T; Hooghiemstra WTR; Ourailidou ME; Kistemaker LE; Bischoff R; Gosens R; Haisma HJ; Dekker FJ Biochem Pharmacol; 2016 May; 108():58-74. PubMed ID: 26993378 [TBL] [Abstract][Full Text] [Related]
10. NuA4 links methylation of histone H3 lysines 4 and 36 to acetylation of histones H4 and H3. Ginsburg DS; Anlembom TE; Wang J; Patel SR; Li B; Hinnebusch AG J Biol Chem; 2014 Nov; 289(47):32656-70. PubMed ID: 25301943 [TBL] [Abstract][Full Text] [Related]
11. Protein acetylation and related potential therapeutic strategies in kidney disease. Li XY; Yu JT; Dong YH; Shen XY; Hou R; Xie MM; Wei J; Hu XW; Dong ZH; Shan RR; Jin J; Shao W; Meng XM Pharmacol Res; 2023 Nov; 197():106950. PubMed ID: 37820854 [TBL] [Abstract][Full Text] [Related]
12. Acetylation of core histones in response to HDAC inhibitors is diminished in mitotic HeLa cells. Patzlaff JS; Terrenoire E; Turner BM; Earnshaw WC; Paulson JR Exp Cell Res; 2010 Aug; 316(13):2123-35. PubMed ID: 20452346 [TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells. Takashina T; Kinoshita I; Kikuchi J; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Nishimura M; Dosaka-Akita H Cancer Sci; 2016 Jul; 107(7):955-62. PubMed ID: 27116120 [TBL] [Abstract][Full Text] [Related]
14. HDACs and HDAC Inhibitors in Cancer Development and Therapy. Li Y; Seto E Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530 [TBL] [Abstract][Full Text] [Related]
15. Assays for Validating Histone Acetyltransferase Inhibitors. Waddell AR; Liao D J Vis Exp; 2020 Aug; (162):. PubMed ID: 32831305 [TBL] [Abstract][Full Text] [Related]
16. 4-Phenybutyric acid promotes gastric cancer cell migration via histone deacetylase inhibition-mediated HER3/HER4 up-regulation. Shi X; Zheng C; Li C; Hou K; Wang X; Yang Z; Liu C; Liu Y; Che X; Qu X Cell Biol Int; 2018 Jan; 42(1):53-62. PubMed ID: 28851073 [TBL] [Abstract][Full Text] [Related]
17. Ginsenoside 20(s)-Rh2 as potent natural histone deacetylase inhibitors suppressing the growth of human leukemia cells. Liu ZH; Li J; Xia J; Jiang R; Zuo GW; Li XP; Chen Y; Xiong W; Chen DL Chem Biol Interact; 2015 Dec; 242():227-34. PubMed ID: 26482938 [TBL] [Abstract][Full Text] [Related]
18. Eaf1 is the platform for NuA4 molecular assembly that evolutionarily links chromatin acetylation to ATP-dependent exchange of histone H2A variants. Auger A; Galarneau L; Altaf M; Nourani A; Doyon Y; Utley RT; Cronier D; Allard S; Côté J Mol Cell Biol; 2008 Apr; 28(7):2257-70. PubMed ID: 18212047 [TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver. Lin T; Chen H; Koustova E; Sailhamer EA; Li Y; Shults C; Liu B; Rhee P; Kirkpatrick J; Alam HB Surgery; 2007 Jun; 141(6):784-94. PubMed ID: 17560255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]